Evergreen Theragnostics
Jersey City
About Evergreen Theragnostics
Evergreen Theragnostics is a contract development and manufacturing platform that provides radiopharmaceutical development services. Founded in 2019, Evergreen Theragnostics rose to prominence as a notable Contract Development and Manufacturing Organization (CDMO) specializing in radiopharmaceuticals within the United States. Benefiting from an unmatched team with extensive expertise and a demonstrated track record in theragnostic radiopharmaceutical commercialization, advancement of manufacturing processes, and management of regulatory affairs, the organization stands as an ideal partner for radiopharmaceutical development, manufacturing, and commercialization needs.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $1K – $10K
- Total funding: $60.0M
- Funding stage: M&A
- Last round: Series C (Apr 2024)
- Website: evergreentgn.com
- Phone: 917-319-1920
Industries & Categories
Biotechnology, Manufacturing
Social Profiles
Canonical: https://fsome.com/organization/evergreen-theragnostics-63723 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.